Global Third-party Medical Central Sterile Supply Department Market Strategic Research Report 2026-2031

Publication ID:

NAV1026014

Publication Date:

October 19, 2026

Pages:

150

Countries:

Global [1]

The global third-party medical central sterile supply department (CSSD) market is valued at approximately USD 1,401 million in 2025 and is projected to reach about USD 2,557 million by 2031, a compound annual growth rate of 10.6% over 2026-2031. The market covers independent providers that clean, inspect, pack and sterilize reusable surgical and medical instruments for hospitals, clinics and other care settings, replacing or supplementing in-house sterile processing. Growth is well above the expansion in hospital procedure volumes because of a structural shift from in-house departments toward outsourced and hybrid models.

Asia Pacific is the growth engine, rising from about USD 495 million in 2025 to USD 1,145 million in 2031 at a 15.0% CAGR, led by China, where licensed third-party CSSD centres grew from 22 in 2020 to 103 in November 2024. North America (USD 400 million in 2025, 8.0% CAGR) and Europe (USD 384 million, 6.5% CAGR) are mature, accreditation-driven markets, while the Middle East and Africa and Latin America are earlier-stage and tied to private hospital expansion. The report also sets out bear, base and bull cases, with 2031 values of USD 2,169 million, USD 2,557 million and USD 3,001 million.

The study sizes realised, billable revenue from outsourced reprocessing of reusable instruments only. Contract sterilization of single-use devices for manufacturers is treated as an adjacent market and excluded. The market is segmented by sterilization method into steam and other methods, ethylene oxide (EO) and irradiation, and by application into hospital, clinic, medical beauty institution and other end users. It is value-based and does not model volumes.

Scope of the Global Third-party Medical Central Sterile Supply Department Market Strategic Research Report

This report provides market sizing and 2026-2031 forecasts by sterilization method, application, region and country, a regional and national outlook across 5 regions, an assessment of growth drivers and inhibitors including ethylene oxide regulation, competitive landscape analysis with profiles of 10 key operators, Porter's Five Forces, PESTLE and SWOT analysis, and long-term outlook to 2035.

Segment by Type

Steam and Other Methods
Ethylene Oxide (EO) Sterilization
Irradiation Sterilization

Segment by Application

Hospital
Clinic
Medical Beauty Institution
Other

Key Companies Profiled

STERIS plc, Getinge AB, SteriPro International Inc., Sotera Health Co., Zhongjin Irradiation Inc., Laoken Medical, Julikang, Jinghong, Sinopharm Jienuo and Jul Union.

Who Can Use This Report?

Sterile-processing and contract-sterilization operators, medical-device and equipment makers weighing a move into services, hospital and health-system procurement and supply-chain teams, private-equity and strategic investors assessing regional operator roll-ups, and consultants and advisers working on outsourcing, infection-control and EO-regulation questions.

1. Executive Summary
1.1 Market Overview and Scope
1.2 Market Size and Growth Outlook
1.3 Key Findings
1.4 Segmentation Insights
    1.4.1 By Sterilization Method
    1.4.2 By Application
1.5 Regional Perspective
1.6 Competitive Landscape
1.7 Growth Drivers and Constraints
1.8 Strategic Implications
1.9 Data Notes and Limitations
2. Industry Overview & Forecast
    2.1.1 Market Definition and Scope
    2.1.2 Market Size in 2025
    2.1.3 Indicative Historical Development, 2022-2025
    2.1.4 Forecast to 2031
    2.1.5 Regional Forecast
    2.1.6 Forecast by Sterilization Method
    2.1.7 Forecast by Application
    2.1.8 Forecast Drivers and Confidence
3. Market Segmentation by Type
3.1 Market Segmentation by Type
    3.1.1 Market by Type Overview
    3.1.2 Steam and Other Methods
    3.1.3 Ethylene Oxide (EO) Sterilization
    3.1.4 Irradiation Sterilization
    3.1.5 Segment Outlook and Analytical Considerations
4. Market Segmentation by Application
4.1 Market Segmentation by Application
    4.1.1 Market by Application Overview
    4.1.2 Hospital
    4.1.3 Clinic
    4.1.4 Medical Beauty Institution
    4.1.5 Other
    4.1.6 Application Outlook and Analyst View
5. Regional Market Forecast
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
6. Country-Level Market Forecast
6.1 North America
    6.1.1 United States
    6.1.2 Canada
    6.1.3 Mexico
    6.1.4 Rest of North America
6.2 Europe
    6.2.1 Germany
    6.2.2 France
    6.2.3 United Kingdom
    6.2.4 Italy
    6.2.5 Russia
    6.2.6 Rest of Europe
6.3 Asia Pacific
    6.3.1 China
    6.3.2 Japan
    6.3.3 South Korea
    6.3.4 Southeast Asia
    6.3.5 India
    6.3.6 Australia
    6.3.7 Rest of Asia Pacific
6.4 Middle East and Africa
    6.4.1 Egypt
    6.4.2 South Africa
    6.4.3 Israel
    6.4.4 Turkey
    6.4.5 GCC Countries
    6.4.6 Rest of Middle East and Africa
6.5 Latin America
    6.5.1 Brazil
    6.5.2 Rest of Latin America
7. Growth Drivers & Inhibitors
7.1 Growth Drivers & Inhibitors
    7.1.1 Market Drivers
    7.1.2 Market Restraints
    7.1.3 Regulation and Standards
    7.1.4 Impact Assessment
    7.1.5 Opportunities & White-Space Analysis
    7.1.6 Analyst Perspective
8. Key Company Profiles
8.1 STERIS plc
    8.1.1 Company Overview
    8.1.2 Key Products & Segments
    8.1.3 Financial Performance (2023–2025)
    8.1.4 Business Strategy
    8.1.5 SWOT Analysis
    8.1.6 Strategic Implications (2025–2031)
8.2 Getinge AB
    8.2.1 Company Overview
    8.2.2 Key Products & Segments
    8.2.3 Financial Performance (2023–2025)
    8.2.4 Business Strategy
    8.2.5 SWOT Analysis
    8.2.6 Strategic Implications (2025–2031)
8.3 SteriPro International Inc.
    8.3.1 Company Overview
    8.3.2 Key Products & Segments
    8.3.3 Financial Performance (2023–2025)
    8.3.4 Business Strategy
    8.3.5 SWOT Analysis
    8.3.6 Strategic Implications (2025–2031)
8.4 Sotera Health Co.
    8.4.1 Company Overview
    8.4.2 Key Products & Segments
    8.4.3 Financial Performance (2023–2025)
    8.4.4 Business Strategy
    8.4.5 SWOT Analysis
    8.4.6 Strategic Implications (2025–2031)
8.5 Zhongjin Irradiation Inc.
    8.5.1 Company Overview
    8.5.2 Key Products & Segments
    8.5.3 Financial Performance (2023–2025)
    8.5.4 Business Strategy
    8.5.5 SWOT Analysis
    8.5.6 Strategic Implications (2025–2031)
8.6 Laoken Medical
    8.6.1 Company Overview
    8.6.2 Key Products & Segments
    8.6.3 Financial Performance (2023–2025)
    8.6.4 Business Strategy
    8.6.5 SWOT Analysis
    8.6.6 Strategic Implications (2025–2031)
8.7 Julikang
    8.7.1 Company Overview
    8.7.2 Key Products & Segments
    8.7.3 Financial Performance (2023–2025)
    8.7.4 Business Strategy
    8.7.5 SWOT Analysis
    8.7.6 Strategic Implications (2025–2031)
8.8 Jinghong
    8.8.1 Company Overview
    8.8.2 Key Products & Segments
    8.8.3 Financial Performance (2023–2025)
    8.8.4 Business Strategy
    8.8.5 SWOT Analysis
    8.8.6 Strategic Implications (2025–2031)
8.9 Sinopharm Jienuo
    8.9.1 Company Overview
    8.9.2 Key Products & Segments
    8.9.3 Financial Performance (2023–2025)
    8.9.4 Business Strategy
    8.9.5 SWOT Analysis
    8.9.6 Strategic Implications (2025–2031)
8.10 Jul Union
    8.10.1 Company Overview
    8.10.2 Key Products & Segments
    8.10.3 Financial Performance (2023–2025)
    8.10.4 Business Strategy
    8.10.5 SWOT Analysis
    8.10.6 Strategic Implications (2025–2031)
9. Competitive Landscape
9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
    9.4.1 Emerging Competitive Threats
    9.4.2 Consolidation versus Fragmentation
    9.4.3 Competitive Response Matrix
    9.4.4 Strategic Recommendations, 2025-2031
10. Porter's Five Forces Analysis
10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry
11. PESTLE Analysis
11.1 PESTLE Analysis
    11.1.1 Political
    11.1.2 Economic
    11.1.3 Social
    11.1.4 Technological
    11.1.5 Legal and Regulatory
    11.1.6 Environmental
    11.1.7 Analyst Perspective on the PESTLE Outlook
12. SWOT Analysis
12.1 SWOT Analysis
    12.1.1 Market-Level Strengths
    12.1.2 Market-Level Weaknesses
    12.1.3 Strategic Opportunities
    12.1.4 External Threats
    12.1.5 SWOT Synthesis and Strategic Implications
13. Future Trends & Outlook
13.1 Future Trends & Outlook
    13.1.1 Regionalization and Chain Operators
    13.1.2 Digital Traceability and Automation
    13.1.3 EO Regulation and Method Mix
    13.1.4 Regional Growth Outlook
    13.1.5 Long-Term Market Outlook (2032-2035)
    13.1.6 Forecast Considerations and Data Limitations
    13.1.7 Investment & Strategic Priorities

List of Exhibits
Exhibit 2.1: Forecast of Global (in USD Bn)
Exhibit 2.2: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
Exhibit 2.3: Forecast of North America (in USD Bn)
Exhibit 2.4: Forecast of Europe (in USD Bn)
Exhibit 2.5: Forecast of Asia Pacific (in USD Bn)
Exhibit 2.6: Forecast of Middle East and Africa (in USD Bn)
Exhibit 2.7: Forecast of Latin America (in USD Bn)
Exhibit 3.8: Forecast of Steam and Other Methods (in USD Bn)
Exhibit 3.9: Forecast of Ethylene Oxide (EO) Sterilization (in USD Bn)
Exhibit 3.10: Forecast of Irradiation Sterilization (in USD Bn)
Exhibit 4.11: Forecast of Hospital (in USD Bn)
Exhibit 4.12: Forecast of Clinic (in USD Bn)
Exhibit 4.13: Forecast of Medical Beauty Institution (in USD Bn)
Exhibit 4.14: Forecast of Other (in USD Bn)
Exhibit 6.15: Forecast of North America (in USD Bn)
Exhibit 6.16: Forecast of United States (in USD Bn)
Exhibit 6.17: Forecast of Europe (in USD Bn)
Exhibit 6.18: Forecast of Germany (in USD Bn)
Exhibit 6.19: Forecast of France (in USD Bn)
Exhibit 6.20: Forecast of United Kingdom (in USD Bn)
Exhibit 6.21: Forecast of Italy (in USD Bn)
Exhibit 6.22: Forecast of Rest of Europe (in USD Bn)
Exhibit 6.23: Forecast of Asia Pacific (in USD Bn)
Exhibit 6.24: Forecast of China (in USD Bn)
Exhibit 6.25: Forecast of Japan (in USD Bn)
Exhibit 6.26: Forecast of South Korea (in USD Bn)
Exhibit 6.27: Forecast of Southeast Asia (in USD Bn)
Exhibit 6.28: Forecast of Middle East and Africa (in USD Bn)
Exhibit 6.29: Forecast of Latin America (in USD Bn)
Exhibit 6.30: Forecast of Brazil (in USD Bn)

STERIS plc
Getinge AB
SteriPro International Inc.
Sotera Health Co.
Zhongjin Irradiation Inc.
Laoken Medical
Julikang
Jinghong
Sinopharm Jienuo
Jul Union

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Enterprise License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.